This project is designed to """"""""build"""""""" a model for the cocaine recognition site using x-ray crystal structures, charge density studies and molecular modelling techniques. The first part of this study is designed to """"""""map"""""""" the three-dimensional structure and electronic character of (-)-cocaine and (-)-norcocaine. The mapping will not only include the overall geometry but will also be done with respect to the net atomic charges, electrostatic potentials, electric field gradients and intermolecular interaction energies. To calculate these quantities, carefully measured experimental x-ray data will be collected to accurately determine the electronic structure of (-)-cocaine and (-)- norcocaine. Routine x-ray crystal structures of several derivatives of cocaine will be completed in order to determine the three-dimensional structures and conformations of these molecules. This information in conjunction with the electronic structure of (-)-cocaine and (-)-norcocaine will be used to model the cocaine recognition site. This will give us a clearer understanding of the charge distribution and structural requirements for drug binding and action that occur at this site. Molecular modeling techniques will be used to """"""""build"""""""" a computer model of the cocaine recognition site. Results from the experimental charge density studies of (-)-cocaine and (-)-nor-cocaine, x-ray crystal structures of cocaine derivatives and other low energy structural conformations obtained through molecular mechanics will be used to """"""""build"""""""" the model.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Resource-Related Research Projects (R24)
Project #
5R24DA007970-03
Application #
3753062
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Xavier University of Louisiana
Department
Type
DUNS #
020857876
City
New Orleans
State
LA
Country
United States
Zip Code
70125
Mayence, Annie; Vanden Eynde, Jean Jacques; Krogstad, Fran M et al. (2004) Parallel solution-phase synthesis of conformationally restricted congeners of pentamidine and evaluation of their antiplasmodial activities. J Med Chem 47:2700-5
Mayence, Annie; Vanden Eynde, Jean Jacques; LeCour Jr, Louis et al. (2004) Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents. Eur J Med Chem 39:547-53
Donkor, Isaac O; Huang, Tien L; Tao, Bin et al. (2003) Trypanocidal activity of conformationally restricted pentamidine congeners. J Med Chem 46:1041-8
Homayoun, P; Mandal, T; Landry, D et al. (2003) Controlled release of anti-cocaine catalytic antibody from biodegradable polymer microspheres. J Pharm Pharmacol 55:933-8
Mandal, Tarun K; Bostanian, Levon A; Graves, Richard A et al. (2002) Poly(D,L-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system. Pharm Res 19:1713-9
Zhang, Qiang; Ma, Peng; Iszard, Marcus et al. (2002) In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist. Drug Metab Dispos 30:1077-86
Brakta, Mohamed; Murthy, Devangachinta; Ellis, L'Ouverture et al. (2002) 9-[(Hydroxymethyl)phenyl]adenines: new aryladenine substrates of adenosine deaminase. Bioorg Med Chem Lett 12:1489-92
Huang, T L; Tao, B; Quarshie, Y et al. (2001) N,N'-bis[4-(N-alkylamidino)phenyl]homopiperazines as anti-Pneumocystis carinii agents. Bioorg Med Chem Lett 11:2679-81
Mandal, T K; Bostanian, L A (2000) Effect of peptide loading and surfactant concentration on the characteristics of physically crosslinked hydrogel. Pharm Dev Technol 5:555-60
Mandal, T K (2000) Swelling-controlled release system for the vaginal delivery of miconazole. Eur J Pharm Biopharm 50:337-43

Showing the most recent 10 out of 17 publications